Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee.
暂无分享,去创建一个
Laurence Leenhardt | P. Grosclaude | L. Leenhardt | Pascale Grosclaude | L. Chérié-Challine | Laurence Chérié-Challine
[1] M. Luster,et al. Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. , 2004, Thyroid : official journal of the American Thyroid Association.
[2] H. Gharib,et al. Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal , 1993, Annals of Internal Medicine.
[3] Macp,et al. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[4] S. Franceschi,et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland , 2003, Cancer Causes & Control.
[5] P. Boyle,et al. Time trend and age‐period‐cohort effect on incidence of thyroid cancer in Connecticut, 1935–1992 , 1996, International journal of cancer.
[6] S. Chevret,et al. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. , 2003, Human pathology.
[7] O. Brawley. Prostate carcinoma incidence and patient mortality , 1997, Cancer.
[8] M. Schlumberger,et al. Papillary and follicular thyroid carcinoma. , 1998, The New England journal of medicine.
[9] E. Hindié,et al. Non-medical exposure to radioiodines and thyroid cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[10] P. Arveux,et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). , 2002, European journal of cancer.
[11] J. Burgess,et al. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency. , 2000, The Journal of clinical endocrinology and metabolism.
[12] L. Akslen,et al. Incidence of thyroid cancer in Norway 1970–1985 , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[13] B Franc,et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. , 1999, The Journal of clinical endocrinology and metabolism.
[14] M. Schlumberger,et al. Advances in diagnostic practices affect thyroid cancer incidence in France. , 2004, European journal of endocrinology.
[15] L. Tabár,et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.
[16] A. Auvinen,et al. Cancer consequences of the Chernobyl accident in Europe outside the former USSR: A review , 1996, International journal of cancer.
[17] Z. Baloch,et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.
[18] A. Sardi,et al. Changing trends in thyroid surgery. 38 years' experience. , 1991, The American surgeon.
[19] M. Spitz,et al. Ethnic patterns of thyroid cancer incidence in the United States, 1973‐1981 , 1988, International journal of cancer.
[20] E. Mittendorf,et al. The results of ultrasound-guided fine-needle aspiration biopsy for evaluation of nodular thyroid disease. , 2002, Surgery.
[21] C. la Vecchia,et al. History of thyroid diseases and subsequent thyroid cancer risk. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] S. Mandel,et al. Usefulness of Ultrasonography in the Management of Nodular Thyroid Disease , 2000, Annals of Internal Medicine.
[23] L. Hegedüs,et al. Management of the solitary thyroid nodule: results of a North American survey. , 2000, The Journal of clinical endocrinology and metabolism.
[24] W C Black,et al. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. , 1993, The New England journal of medicine.
[25] A. Renshaw,et al. Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. , 2002, American journal of clinical pathology.
[26] A. Ugnat,et al. Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects , 2001, British Journal of Cancer.
[27] T. Haldorsen,et al. Positive correlation between parity and incidence of thyroid cancer: New evidence based on complete Norwegian birth cohorts , 1991, International journal of cancer.